since the suspicion exists that low levels of endogenous lps may potentiate tsst-1 activity during clinical toxic shock syndrome , we hypothesized that endotoxin-neutralizing antibodies could be useful in the treatment of this lethal disease process .
C0023810
lps
C0014264
endotoxin